Can a simple check at discharge prevent medication errors?
NCT ID NCT05062655
First seen Jul 01, 2026 · Last updated Jul 02, 2026 · Updated 1 time
Summary
This trial tests whether a coordinated drug reconciliation process — where a pharmacist reviews and communicates a patient's medications at discharge — can reduce treatment interruptions and improve safety. The study includes hospitalized children and adults who need special medication supplies. The goal is to see if this organized handoff leads to fewer days without necessary medication after leaving the hospital.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- Drug reconciliation process
- What this could lead to
- If effective, this coordinated process could reduce medication errors and rehospitalizations, making hospital discharges safer for patients.
- What could go wrong
- This is a small, single-center study (82 patients) testing a process change, not a new drug. Results may not apply to other hospitals or patient groups.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
82 people
The number who actually took part.
- Started
-
Nov 2021
- Finished
-
Nov 2022
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
Children (under 18), adults (18 to 64) and older adults (65 and over)
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * hospitalized patient * Patient with a drug treatment with a particular mode of supply * Paediatric patient or an adult patient. * First inpatient stay over the inclusion period from late 2021 to late 2022 Exclusion Criteria: * Patient under curatorship or guardianship * Patient residing abroad * No free, informed and written consent obtained
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Hospitalized patient are added.
Genom att skicka in godkänner du våra Användarvillkor
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Centre Hospitalier Du Mans
Le Mans, 72000, France
More trials for these conditions
Other studies related to the condition(s) this trial covers.